Skip to main content
    H

    Halozyme Therapeutics Inc (HALO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $95.97
    -0.53 (-0.55%)

    Market Cap: $11.00B

    Last updated: Nov 17, 2026 at 4:37 PM ET

    Halozyme Therapeutics Inc (HALO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Halozyme Therapeutics (HALO) has a latest price of $95.97 on Nov 17, 2026, 28.4% below its 52-week high of $134.00. Its price rose 37.0% over the past 12 months. The month-end price rose 1,416.9% over the 10 years through Oct 2026, a compound annual rate of 31.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $130.91 in Oct 2026 and its lowest $8.63 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart HALO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HALO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 10.8%, and over 6 months it rose 39.6%. The month-end price rose 286.5% over the 3 years through Oct 2026, a compound annual rate of 56.9%.

    PeriodChange
    1 month-21.7%
    3 months-10.8%
    6 months+39.6%
    12 months+37.0%
    12 months, with dividends+37.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+286.5%+56.9%
    5 years+243.9%+28.0%
    10 years+1,416.9%+31.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 140.9%, and its weakest was 2023, when it fell 35.0%.

    YearCloseChange
    2026 through Oct 2026$130.91+94.5%
    2025$67.30+40.8%
    2024$47.81+29.4%
    2023$36.96-35.0%
    2022$56.90+41.5%
    2021$40.21-5.9%
    2020$42.71+140.9%
    2019$17.73+21.2%
    2018$14.63-27.8%
    2017$20.26+105.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 15.8% below its 50-day average of $114.04 and 12.0% above its 200-day average of $85.66.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$95.97
    52-week high$134.00-28.4%
    52-week low$61.23+56.7%
    50-day average$114.04-15.8%
    200-day average$85.66+12.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 33.9%.

    MeasureValue
    1-year beta0.62
    Largest fall, 1 year-26.8%
    Largest fall, 3 years-33.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Halozyme Therapeutics traded at 16.3x earnings at the end of 2025, against a 5-year median of 15.8x.

    HALO valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About HALO

    What is HALO's 1-year price change?

    Halozyme Therapeutics's price rose 37.0% over the past 12 months. With dividends included, the 12-month total return was 37.0%.

    What is HALO's 5-year price change?

    Halozyme Therapeutics's month-end price rose 243.9% over the 5 years through Oct 2026, a compound annual rate of 28.0%. These figures leave out dividends.

    What is HALO's 52-week high and low?

    Halozyme Therapeutics's 52-week high is $134.00 and its 52-week low is $61.23. Its latest price of $95.97 on Nov 17, 2026 is 28.4% below the high.

    What is HALO's beta?

    Halozyme Therapeutics's 1-year beta against the S&P 500 is 0.62, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 26.8%.

    Is the HALO chart free?

    Yes. Advanced Charting for HALO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.